Siddhartha De

Drug Discovery Facility, Plot-9, Phase I, Rajiv Gandhi Infotech Park, Hinjewadi, Pune 411 057
Pune, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.

Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.

Journal: Bioorganic & medicinal chemistry letters

Published: October 08, 2018

Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.

Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: April 24, 2017

Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and Depression.

Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and Depression.

Journal: ACS medicinal chemistry letters

Published: April 22, 2017

Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation.

Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation.

Journal: Journal of medicinal chemistry

Published: January 06, 2017

Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.

Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.

Journal: European journal of medicinal chemistry

Published: December 26, 2016

Discovery and evaluation of 1H-pyrrolo[2,3-b]pyridine based selective and reversible small molecule BTK inhibitors for the treatment of rheumatoid arthritis.

Discovery and evaluation of 1H-pyrrolo[2,3-b]pyridine based selective and reversible small molecule BTK inhibitors for the treatment of rheumatoid arthritis.

Journal: Bioorganic & medicinal chemistry letters

Published: December 13, 2016

Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation.

Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation.

Journal: Bioorganic & medicinal chemistry

Published: November 16, 2016

Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases.

Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases.

Journal: European journal of medicinal chemistry

Published: November 15, 2016

Rational design, synthesis, and structure-activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.

Rational design, synthesis, and structure-activity relationships of 5-amino-1H-pyrazole-4-carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: August 08, 2016

Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.

Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.

Journal: Bioorganic & medicinal chemistry letters

Published: April 08, 2012

Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.

Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: September 30, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026